Soleno Therapeutics (SLNO) Share-based Compensation (QoQ) (2014 - 2026)
Soleno Therapeutics (SLNO) Share-based Compensation (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 803.15% |
| Dec 31, 2025 | 14.73% |
| Sep 30, 2025 | 3.09% |
| Sep 30, 2024 | 690.47% |
| Jun 30, 2024 | 11.09% |
| Mar 31, 2024 | 259.69% |
| Dec 31, 2023 | -283.37% |
| Sep 30, 2023 | 82.81% |
| Jun 30, 2023 | 90.81% |
| Mar 31, 2023 | -0.16% |
| Dec 31, 2022 | -7.47% |
| Sep 30, 2022 | 19.61% |
| Jun 30, 2022 | -11.34% |
| Mar 31, 2022 | -79.59% |
| Dec 31, 2021 | 248.34% |
| Sep 30, 2021 | 5.72% |
| Jun 30, 2021 | 614.17% |
| Mar 31, 2021 | -69.47% |
| Dec 31, 2020 | 5.08% |
| Sep 30, 2020 | 9.68% |